A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
Status:
Not yet recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
A phase IIb clinical study to evaluate the safety and efficacy of single or multiple doses of
LT3001 drug product in subjects with acute ischemic stroke (AIS) undergoing endovascular
thrombectomy (EVT).